Latest 8-K filings

Anavex Life Sciences Corp. held its 2026 Annual Meeting of Stockholders, confirming director elections and auditor ratification, while also triggering a change in control event.

Viking Therapeutics announced the successful closing of both an equity offering and a debt offering, raising a combined total of approximately $547.8 million to fund its clinical development programs.

Sabre Corporation's subsidiaries, Sabre Financial and Sabre GLBL, have completed significant debt refinancing and tender offers, issuing new notes and repurchasing older, higher-interest debt.

Ameren Missouri has submitted its 2026 Integrated Resource Plan to the Missouri Public Service Commission, outlining a strategy for future energy needs including substantial investments in renewables, natural gas, and nuclear power.

Ameren Missouri has submitted its 2026 Integrated Resource Plan to the Missouri Public Service Commission, outlining a strategy for future energy needs including substantial investments in renewables, natural gas, and nuclear power.

AST SpaceMobile, Inc. has adopted a new Senior Management Change of Control Severance Policy designed to provide financial security to key executives.

Kodiak Gas Services, Inc. has filed an amendment to its 8-K report to include unaudited pro forma combined financial information for the six months ended June 30, 2026, reflecting the acquisition of Distributed Power Solutions, LLC.

Kodiak Gas Services, Inc. has filed a Certificate of Elimination to remove Series A Preferred Stock provisions from its charter, as no shares are outstanding or will be issued.

Nexalin Technology receives conditional Nasdaq continued listing approval, requiring immediate bid price compliance and future equity targets.

U.S. Physical Therapy, Inc. has entered into a 45-month forward-starting interest rate swap agreement to hedge against variable interest rate fluctuations on its term debt.

CervoMed announces a new 50 mg oral tablet formulation for neflamapimod, coupled with FDA removal of a drug exposure limit, enabling a higher-dose, twice-daily regimen for future clinical trials.

Accendra Health, Inc. amends prior filing to confirm October 5, 2026, as the effective start date for new CEO Kenneth Gardner-Smith and details Edward Pesicka's consulting role.

Faraday Future Intelligent Electric Inc. has entered into a non-binding term sheet to sell its robotics business to its majority-owned subsidiary, AIxCrypto Holdings, Inc., for approximately $200 million.

San Juan Basin Royalty Trust provides an operational and liquidity update, detailing administrative expense reductions and addressing a joint interest audit adjustment, while managing a credit facility renewal.

Inhibrx Biosciences shared updated corporate information, focusing on positive clinical trial results for INBRX-106 and INBRX-109, and outlining future development milestones.

NeOnc Technologies Holdings, Inc. announced a scheduled End-of-Phase 1 meeting with the FDA on November 17, 2026, to discuss the development of its CNS cancer therapy, NEO212.

AAR Corp. announced robust first quarter fiscal year 2027 financial results, with sales up 24% to $918 million, and also revealed an agreement to acquire a controlling interest in MRO Holdings.

RingCentral, Inc. has announced its 2026 Annual Meeting of Stockholders will be held on November 2, 2026, with specific deadlines for shareholder proposals and director nominations set for October 9, 2026.

PCB Bancorp announced its Board of Directors has approved a share repurchase program authorizing the repurchase of up to 700,000 shares of its common stock.

Viking Acquisition Corp. I announces its business combination with NorthStar Earth & Space Inc. is expected to close on September 30, 2026, with the combined entity to trade as NorthStar Earth & Space Enterprises, Inc. on NYSE American.

StandardAero, Inc. announced the departure of its Chief Operating Officer, Kimberly Ernzen, effective September 28, 2026, with plans for a transition agreement.

Azitra, Inc. has entered into an at-the-market sales agreement with A.G.P./Alliance Global Partners to potentially sell up to $3,503,232 of its common stock.

CAMP4 Therapeutics Corporation provided updates on its Phase 1/2 ASCEND clinical trial for CMP-002 in SYNGAP1-related disorder and its broader pipeline at an Analyst Day meeting.

Jasper Therapeutics announced the resignation of its CFO, Herb Cross, effective October 9, 2026, with interim appointments made to fill the key financial roles.

Greenland Mines Ltd. announced a direct registered offering of 1,320,000 shares of common stock to certain institutional investors, raising approximately $17.2 million in net proceeds.

SilverBox Corp IV announced the delisting of its units, Class A ordinary shares, and warrants from the New York Stock Exchange, effective September 28, 2026, with trading moving to the OTC Markets.

McCormick & Company announced the dismissal of Ernst & Young LLP as its independent auditor, effective upon the filing of its annual report, and the engagement of KPMG LLP.

Keurig Dr Pepper Inc. has completed transactions with Chobani, involving the redemption of equity interests and the sale of assets, for a total consideration of $925 million.

Marwynn Holdings, Inc. has filed an 8-K to announce the adoption of its Third Amended and Restated Bylaws, effective September 25, 2026, to align with Nevada Revised Statutes.

IDT Corporation announced record fourth quarter and full fiscal year 2026 results, showcasing significant year-over-year growth in gross profit, income from operations, and Adjusted EBITDA across its key business segments.